RBL001/RBL002 Phase I Clinical Trial
Trial status:Study Complete
Study Identifier:
RB_0001-01
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
The sponsor of a clinical trial is the company, institution or individual that takes responsibility for initiating, managing, and/or financing a clinical investigation. BioNTech collaborates with other pharmaceutical companies or institutions (collaborators) to develop certain new medicines. In particular cases BioNTech's collaborators are leading specific clinical trials and are acting as sponsors accordingly.
BioNTech RNA Pharmaceuticals GmbH
Study Complete
Trial details
Medical Condition
Study Drug
Phase
Phase 1
Sex
Female & Male
Age
18+
Estimated Trial Date
Jun 2012 - May 2015
Protocol summary
Clinical first-in-human dose escalation study evaluating the safety and tolerability of intranodal administration of an RNA-based cancer vaccine targeting two tumor-associated antigens in patients with advanced melanoma
Trial locations
Location
Status
Location
Medizinische Universität Wien, Abteilung für Dermatologie
Vienna, Austria, A-1090
Status
Location
Medizinische Fakultät der Universität Duisburg-Essen
Essen, Germany, 45122
Status
Location
Universtitätsmedizin der Johannes-Gutenberg Universtität
Mainz, Germany, 55131
Status
Location
Universitätsklinik Mannheim
Mannheim, Germany
Status